Articles available: 148

CONTINUING SCIENTIFIC EDUCATION IN VETERINARY MEDICINE

Monday, 28 November 2022

Efficacy of oclacitinib for the treatment of canine cutaneous lupus erythematosus

  • The time to complete remission was around 2 months
Rate this item
(0 votes)

lupus cutaneo dogThe treatment of canine chronic cutaneous lupus erythematosus (CCLE) variants generally requires immunosuppression, which often results in potentially severe adverse effects. Janus kinase inhibitors, like oclacitinib, might be a valuable treatment option due to their rapid inhibition of the action of interferons known to be relevant in the pathogenesis of CCLE.

The aim of this study was to report the efficacy and safety of oral oclacitinib for the treatment of canine CCLE variants.

To read the complete article, you must log in with your EGO account.

Written by
Michele Tumbarello Med Vet PhD student

Read 27 times Last modified on Tuesday, 22 November 2022 16:46

vetchannel nero

VETCHANNEL.IT
Professional training on demand
when you want, where you want.

eveditoria Scientific Publishing

0
Shares